Dr. Rahul Anil Sheth, MD

Dr. Sheth practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Sheth's NPI, 1932337979, was assigned on June 29, 2009. Dr. Sheth graduated from Harvard Medical School in 2009. Dr. Sheth holds Texas license Q4283.

Dr. Sheth's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Sheth's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sheth practices. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Sheth's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Sheth is board certified in interventional radiology and diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Sheth's licenses on file in 13 states: Texas, Florida, Illinois, Arizona, Mississippi, Tennessee, Washington, Alabama, Georgia, Louisiana, Oklahoma, Massachusetts and Pennsylvania.

CMS data shows 99 Medicare services from Dr. Sheth across 7 procedure codes in 2024, for 123 Medicare patients. Medicare paid $7,103 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 123 Medicare patients who saw Dr. Sheth in 2024. The largest group is 65 to 74, with 71 patients. 75% of them have high blood pressure, and 70% have high cholesterol. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sheth's median patient age at 67, with 31% women.

In 2024, Dr. Sheth wrote 11 Medicare Part D claims. 100% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Sheth for performance year 2024, reported as part of a group. Dr. Sheth accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sheth as offering telehealth.

Dmand AI links 167 papers to Dr. Sheth, published from 2009 to 2025. 2024 was the busiest year, with 14. The most frequent topics are Liver Neoplasms, Embolization, Therapeutic and Immunotherapy. Dr. Sheth has published most often in J Vasc Interv Radiol. Dr. Sheth's most frequent co-authors are Alda Lui Tam, MD, Joshua David Kuban, MD, MMSC and Bruno Calazans Odisio, MD.

Dmand AI links Dr. Sheth to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Carcinoma, Transitional Cell and Thyroid Neoplasms.

CMS Open Payments shows 498 general payments to Dr. Sheth from 28 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 43% of the total. Boston Scientific Corporation paid the most, $135,217. It also lists 4 research payments totaling $17,014 in 2024.

Dr. Sheth graduated from Harvard Medical School in 2009.

Dr. Sheth is in network with 6 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 4. Check the plan with the practice before a visit.